- Pharmacological characteristics of metamizole - (https://pubmed.ncbi.nlm.nih.gov/24724493/ )
- Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405027/ )
- Real world evidence of the use of metamizole (dipyrone) by the Brazilian population. A retrospective cohort with over 380,000 patients - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060643/ )
- Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory Drugs - (https://pubmed.ncbi.nlm.nih.gov/27346584/)
It belongs to the group non-steroidal anti-inflammatory drugs (NSAIDs).
It has been banned in several countries including the United States and India due to its ability to reduce white blood cell counts and cause a condition called agranulocytosis.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Andep (0.25mg) - Ravian Pharmaceuticals Pvt. Ltd.
Andep (0.25mg) Tablet
Generic : Metamizole
Substitute/Alternative Medication to Andep (0.25mg)
When is Andep (0.25mg) prescribed?
It is prescribed for -